Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 2
2009 6
2010 1
2012 1
2013 2
2015 6
2016 4
2017 8
2018 6
2019 9
2020 15
2021 14
2022 8
2023 11
2024 8
2025 9
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

101 results

Results by year

Filters applied: . Clear all
Page 1
Real-world efficacy of immune checkpoint inhibitors in PD-L1 negative non-small cell lung cancer: a multicenter retrospective study.
Muraoka S, Kobayashi N, Kaneko A, Somekawa K, Kajita Y, Hirose T, Tanaka A, Teranishi S, Miura K, Yumoto K, Tsukahara T, Fukuda N, Nishihira R, Horita N, Hara Y, Kudo M, Miyazawa N, Kaneko T. Muraoka S, et al. Among authors: kudo m. Transl Lung Cancer Res. 2025 Jul 31;14(7):2636-2645. doi: 10.21037/tlcr-2025-138. Epub 2025 Jul 28. Transl Lung Cancer Res. 2025. PMID: 40799438 Free PMC article.
MiR-200a regulates PD-L1 and predicts response to immune checkpoint inhibitors in advanced non-small cell lung cancer.
Kaneko A, Kobayashi N, Kubo S, Nagaoka S, Muraoka S, Fukuda N, Somekawa K, Matsumoto H, Katakura S, Teranishi S, Watanabe K, Horita N, Hara Y, Kudo M, Kaneko T. Kaneko A, et al. Among authors: kudo m. Transl Lung Cancer Res. 2025 Jul 31;14(7):2522-2536. doi: 10.21037/tlcr-2025-117. Epub 2025 Jul 28. Transl Lung Cancer Res. 2025. PMID: 40799431 Free PMC article.
Nationwide surveillance of antibacterial susceptibility in bacterial respiratory pathogens in Japan, 2022-2023.
Tokimatsu I, Fujikura Y, Matsumoto T, Tsukada H, Miki M, Morinaga Y, Sato J, Takahashi S, Hasegawa N, Yanagisawa H, Sasaki T, Tamaru N, Takahashi H, Kurai D, Uwamino Y, Kudo M, Nagano Y, Youkou A, Kawasaki S, Tabata A, Iinuma Y, Miyajima Y, Yamamoto Y, Mikamo H, Ohta H, Maruyama T, Nakamura A, Shirano M, Fujikawa Y, Fukumori T, Ogawa T, Kakeya H, Yoshida K, Utsunomiya K, Kobashi Y, Tokuyasu H, Hino S, Yatera K, Fujita M, Yanagihara K, Kosai K, Hiramatsu K, Muranaka H, Shinzato T. Tokimatsu I, et al. Among authors: kudo m. J Infect Chemother. 2025 Oct;31(10):102781. doi: 10.1016/j.jiac.2025.102781. Epub 2025 Aug 6. J Infect Chemother. 2025. PMID: 40774506
Efficacy and safety of intrapleural administration of sodium bicarbonate in patients with acute empyema and complicated parapneumonic effusion: protocol for a prospective, single-arm, interventional study.
Suzukawa Y, Teranishi S, Takakura S, Nakadegawa R, Okazaki S, Tanaka A, Matsushita S, Muraoka T, Hirose T, Maeda C, Seki K, Tashiro K, Kobayashi N, Yamamoto M, Kudo M, Kaneko T. Suzukawa Y, et al. Among authors: kudo m. BMC Infect Dis. 2025 Apr 22;25(1):580. doi: 10.1186/s12879-025-11002-5. BMC Infect Dis. 2025. PMID: 40264031 Free PMC article.
TRIAL REGISTRATION: This study was approved by the Yokohama City University Clinical Research Review Committee (ethics approval number: CRB24-001) on May 8, 2024, and registered with the Japan Clinical Trials Registry (jRCTs031240093) on May 17, 2024. ...
TRIAL REGISTRATION: This study was approved by the Yokohama City University Clinical Research Review Committee (ethics …
Rapid detection of non-small cell lung cancer driver mutations using droplet digital polymerase chain reaction analysis of bronchial washings: a prospective multicenter study.
Somekawa K, Kobayashi N, Nagaoka S, Seki K, Kajita Y, Muraoka S, Izawa A, Kaneko A, Otsu Y, Hirata M, Kubo S, Nagasawa R, Murohashi K, Fuji H, Teranishi S, Tashiro K, Watanabe K, Horita N, Hara Y, Kudo M, Kaneko T. Somekawa K, et al. Among authors: kudo m. Transl Lung Cancer Res. 2025 Feb 28;14(2):353-362. doi: 10.21037/tlcr-24-772. Epub 2025 Feb 22. Transl Lung Cancer Res. 2025. PMID: 40114932 Free PMC article.
Total baseline tumor size predicts survival among patients with advanced small-cell lung cancer receiving chemotherapy plus programmed death-ligand 1 inhibitor as first-line therapy: a multicenter retrospective observational study.
Tanaka A, Teranishi S, Kajita Y, Hirose T, Kaneko A, Sairenji Y, Kawashima H, Yumoto K, Tsukahara T, Miura K, Kobayashi N, Yamamoto M, Nishihira R, Kudo M, Miyazawa N, Nishikawa M, Kaneko T. Tanaka A, et al. Among authors: kudo m. Front Oncol. 2024 Nov 4;14:1400277. doi: 10.3389/fonc.2024.1400277. eCollection 2024. Front Oncol. 2024. PMID: 39558947 Free PMC article.
101 results